EMA CS clinical trials and its 2 linked instruments

How to read this page

Details: Guide Definitions: every term and label explained

EMA CS clinical trialsEMA eSource paper (2010)EMA notice: CS in trials
AuthorityEMAEMAEMA
Legal weightGuidance & Q&AGuidance & Q&AGuidance & Q&A
StatusFinalSupersededFinal
Last verifiedNot yetNot yetNot yet
Summary

EMA guideline for clinical trials on computerised systems and electronic data. It covers data integrity, responsibilities, validation, audit trails, user management, security, data migration and archiving, and it includes artificial intelligence. It replaced the 2010 reflection paper on electronic source data.

Earlier EMA reflection paper on electronic source data in clinical trials. EMA has replaced it with the Guideline on computerised systems and electronic data in clinical trials.

EMA notice to clinical trial sponsors on validating and qualifying computerised systems, such as electronic case report forms and patient reported outcome tools.

Lifecycle
  • 18 Jun 2021 Public consultation started
  • 17 Dec 2021 Public consultation closed
  • 7 Mar 2023 Final version adopted by the GCP Inspectors Working Group
  • 10 Mar 2023 Final version published
  • 9 Jun 2010 Adopted by the GCP Inspectors Working Group
  • 1 Aug 2010 Came into effect
  • 10 Mar 2023 Replaced by the 2023 guideline
  • 7 Apr 2020 First published
  • 29 Oct 2026 Revision 1: administrative update of references
SourceOfficial text
Source: EMA.
Official text
Source: EMA.
Official text
Source: EMA.

These facts are placed side by side from each record. This page does not say which is stricter or whether requirements differ. Read the official texts.